Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Breast Cancer · Prostate Cancer · UTHR

United Therapeutics Europe

United Therapeutics Europe Ltd

United Therapeutics Europe clinical programs — 1032 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
1032
Drugs
612
Patents
3720
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

United Therapeutics Europe projects

1,032 ClinicalTrials.gov programs sponsored by United Therapeutics Europe.

United Therapeutics Europe has 1,032 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,032 programs

Clinical programs

Page 12 of 22

  1. rF1V-1018

    United Therapeutics Europe Ltd

    Plague, Pneumonic

    phase 2 mab completed

    1 trial

  2. rituximab

    United Therapeutics Europe Ltd

    Lymphoma

    phase 2 mab completed

    1 trial

  3. sublingual nitroglycerine

    United Therapeutics Europe Ltd

    COLIC

    phase 2 small molecule active

    1 trial

  4. treprostinil dienthanolmine sustained release

    United Therapeutics Europe Ltd

    Critical Limb Ischemia

    phase 2 small molecule completed

    1 trial

  5. treprostinil diethanolamine

    United Therapeutics Europe Ltd

    Systemic Sclerosis

    phase 2 small molecule completed

    2 trials

  6. trihexyphenidyl

    United Therapeutics Europe Ltd

    Dystonia

    phase 2 small molecule completed

    1 trial

  7. zinc supplementation

    United Therapeutics Europe Ltd

    HIV Infections

    phase 2 small molecule completed

    1 trial

  8. 091

    United Therapeutics Europe Ltd

    HIV Infections

    phase 1 mab completed

    1 trial

  9. 15/0483

    United Therapeutics Europe Ltd

    Head and Neck Fibrosis

    phase 1 other completed

    1 trial

  10. 18F-PEG6-IPQA

    United Therapeutics Europe Ltd

    Lung Cancer

    phase 1 small molecule completed

    1 trial

  11. 3-dimensional conformal radiation therapy

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 1 other active

    1 trial

  12. 31254

    United Therapeutics Europe Ltd

    HIE - Perinatal Hypoxic - Ischemic Encephalopathy

    phase 1 small molecule completed

    1 trial

  13. 89Zr-DFO-YS5

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 1 small molecule active

    1 trial

  14. ARN-75039 oral capsules

    United Therapeutics Europe Ltd

    Healthy Adult Participants

    phase 1 small molecule completed

    1 trial

  15. ASTX660

    United Therapeutics Europe Ltd

    Advanced Cancer

    phase 1 small molecule active

    1 trial

  16. ATRA

    United Therapeutics Europe Ltd

    Pancreatic Adenocarcinoma

    phase 1 small molecule completed

    1 trial

  17. AZD2014 3 on/4 off & weekly paclitaxel

    United Therapeutics Europe Ltd

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  18. Acceptance and Commitment Therapy

    United Therapeutics Europe Ltd

    Stroke

    phase 1 other completed

    1 trial

  19. Administration of UI087

    United Therapeutics Europe Ltd

    Diabetes Mellitus (Type 2)

    phase 1 small molecule active

    1 trial

  20. Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)

    United Therapeutics Europe Ltd

    Urothelial Carcinoma

    phase 1 mab active

    1 trial

  21. Allogeneic (MSC's) Application to the Burn Wounds

    United Therapeutics Europe Ltd

    Skin Burn Degree Second

    phase 1 mab completed

    1 trial

  22. Allogeneic MSC

    United Therapeutics Europe Ltd

    Mesenchymal Stromal Cells

    phase 1 mab completed

    1 trial

  23. Anplag

    United Therapeutics Europe Ltd

    Healthy

    phase 1 small molecule completed

    1 trial

  24. Anti CS6 BSIgG product (Lot PD1601105CS)

    United Therapeutics Europe Ltd

    Healthy Volunteer

    phase 1 mab completed

    1 trial

  25. Antibody UB-421

    United Therapeutics Europe Ltd

    HIV-1 Infection in Adults (Asymptomatic)

    phase 1 small molecule completed

    1 trial

  26. Atovaquone Oral Suspension

    United Therapeutics Europe Ltd

    Locally Advanced Non-Small Cell Lung Cancer

    phase 1 small molecule completed

    1 trial

  27. Autologous Engineered Urethral Construct

    United Therapeutics Europe Ltd

    Urologic Diseases

    phase 1 mab active

    1 trial

  28. Autologous Human Schwann Cell

    United Therapeutics Europe Ltd

    Peripheral Nerve Injury

    phase 1 mab active

    1 trial

  29. Autologous tissue engineered corpora

    United Therapeutics Europe Ltd

    Urologic Diseases

    phase 1 mab active

    1 trial

  30. BIO 300 Oral Powder

    United Therapeutics Europe Ltd

    Acute Radiation Syndrome

    phase 1 small molecule completed

    1 trial

  31. Biospecimen Collection

    United Therapeutics Europe Ltd

    Glioma

    phase 1 other active

    1 trial

  32. CABG + Mitral valve annuloplasty

    United Therapeutics Europe Ltd

    Mitral Regurgitation

    phase 1 other completed

    1 trial

  33. CCT3833

    United Therapeutics Europe Ltd

    Melanoma

    phase 1 small molecule completed

    1 trial

  34. CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine

    United Therapeutics Europe Ltd

    HER2 Negative Breast Carcinoma

    phase 1 mab active

    1 trial

  35. CE marked Philips Motiva system

    United Therapeutics Europe Ltd

    COPD

    phase 1 other completed

    1 trial

  36. CHR-2797 (tosedostat)

    United Therapeutics Europe Ltd

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  37. COVID-HIG

    United Therapeutics Europe Ltd

    SARS-CoV-2 Infection

    phase 1 mab completed

    1 trial

  38. COVID-HIGIV

    United Therapeutics Europe Ltd

    COVID-19

    phase 1 mab completed

    1 trial

  39. CXD101

    United Therapeutics Europe Ltd

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  40. Cabozantinib Oral Tablet

    United Therapeutics Europe Ltd

    Neurofibromatosis 1

    phase 1 small molecule active

    1 trial

  41. Cam2020 M2SR H3N2 influenza vaccine

    United Therapeutics Europe Ltd

    Influenza Vaccine

    phase 1 mab completed

    1 trial

  42. Campylobacter jejuni strain CG8421

    United Therapeutics Europe Ltd

    Campylobacter Infections

    phase 1 mab active

    1 trial

  43. Carbidopa

    United Therapeutics Europe Ltd

    Multiple Sclerosis

    phase 1 small molecule completed

    1 trial

  44. Chlorhexidine

    United Therapeutics Europe Ltd

    Peri-Implantitis

    phase 1 small molecule active

    1 trial

  45. Cisplatin

    United Therapeutics Europe Ltd

    Advanced Cholangiocarcinoma

    phase 1 small molecule terminated

    1 trial

  46. Clinical Center Reference Endotoxin (CCRE)

    United Therapeutics Europe Ltd

    Healthy

    phase 1 small molecule completed

    1 trial

  47. Cyclophosphamide

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 1 small molecule active

    1 trial

  48. D/ChAd63-CA

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

Frequently asked questions

How many clinical projects does United Therapeutics Europe have?

1,032 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.